Related Experiment Videos

Antinociceptive effect of morphine microinjections into the spinal trigeminal subnucleus oralis

P Luccarini1, R Cadet, M Saade

  • 1Laboratoire de Physiologie Oro-Faciale, Faculté Chirurgie Dentaire, Clermont-Ferrand, France.

Neuroreport
|January 26, 1995
PubMed

Insights

Morphine microinjections into the subnucleus oralis (SNO) significantly reduced orofacial pain in rats. This pain relief was dose-dependent and reversed by naloxone, indicating the SNO

Area of Science:

  • Neuroscience
  • Pain Research
  • Pharmacology

Background:

  • Orofacial pain is a significant clinical challenge.
  • The spinal trigeminal nucleus plays a crucial role in processing facial pain signals.
  • The subnucleus oralis (SNO), a rostral division, is implicated in nociceptive mechanisms.

Purpose of the Study:

  • To investigate the analgesic effects of morphine microinjections into the SNO.
  • To determine the role of the SNO in orofacial pain modulation.

Main Methods:

  • The formalin test was adapted for orofacial pain in rats.
  • Morphine or saline was microinjected into the SNO.
  • Rubbing behavior, indicative of pain, was measured after formalin injection.

Main Results:

  • Morphine microinjections into the SNO significantly reduced rubbing behavior in a dose-dependent manner.
  • The analgesic effect of morphine was reversed by naloxone, confirming opioid receptor involvement.
  • Morphine microinjections into adjacent areas did not produce similar analgesic effects, indicating SNO site-specificity.

Conclusions:

  • The subnucleus oralis (SNO) is involved in the central processing of orofacial nociception.
  • Microinjections of morphine into the SNO exert significant analgesic effects on orofacial pain.
  • These findings support the SNO as a potential target for managing orofacial pain.

Related Concept Videos